Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00849563 · ClinicalTrials.gov registry record · NA
Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 450
- Enrollment target
NCT00849563: Completed NA study, sponsored by Duke University.
NCT00849563 is a NA study that has completed, run by Duke University. The registered enrollment target is 450 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00849563, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
Study Summary
The primary objective of the study is to assess the clinical utility of a genetic test for Type 2 diabetes risk in combination with standardized risk assessment compared with standardized risk assessment alone, and to measure whether changes in perceived risk following genetic testing for Type 2 diabetes risk are correlated with behavior change and increased concern about risk for Type 2 diabetes.
Interventions
- OTHER Standardized Risk Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2009-04 |
| Est. Completion | 2013-06 |
| Phase | NA |
What the finished NCT00849563 record still lists
NCT00849563 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 1 intervention - of which Standardized Risk Assessment is the first listed.
NCT00849563 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00849563 about?
NCT00849563 is a clinical study titled "Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes". The primary objective of the study is to assess the clinical utility of a genetic test for Type 2 diabetes risk in combination with standardized risk assessment compared with standardized risk assessment alone, and to measure whether changes in perceived risk following genetic testing for Type 2 dia...
What is the current status of trial NCT00849563?
This trial is currently completed. It is a NA study. The enrollment target is 450 participants. The study started on 2009-04. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00849563?
The interventions under investigation include: Standardized Risk Assessment (OTHER).
Who is sponsoring clinical trial NCT00849563?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00849563's enrollment target sits among peer trials
450 225th of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia